Merck & Co logo

Merck & Co dividend paid (ttm)NYSE: MRK

Dividend paid (TTM)

$764.30 B
+$10.10 B+1.34%

30 June 2024

new highvs 3 years high
+17.42%vs 3 years low
99.15%vs. sector
Performance
Most recent+1.3%
1 year+4.1%
3 years+17.4%
5 years+37.3%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (TTM) performance

Most recent change
MRK+1.3%
AZN-0.1%
NVS0.0%
TMO+2.7%
DHR-0.3%
1 year change
MRK+4.1%
AZN-0.4%
NVS+5.1%
TMO+13.1%
DHR+45.6%
3 years change
MRK+17.4%
AZN+15.7%
NVS+3.5%
TMO+50.4%
DHR+66.4%
5 years change
MRK+37.3%
AZN+24.2%
NVS+14.7%
TMO+97.2%
DHR+141.6%

Dividend paid (TTM) performance

MRKAZNNVSTMOABTISRGDHR
Most recent+1.3%-0.1%0.0%+2.7%---0.3%
1 year+4.1%-0.4%+5.1%+13.1%--+45.6%
3 years+17.4%+15.7%+3.5%+50.4%--+66.4%
5 years+37.3%+24.2%+14.7%+97.2%--+141.6%
FAQ

What is Merck & Co dividend paid (ttm)?

Merck & Co dividend paid (ttm) is $764.30 B

What is Merck & Co dividend paid (ttm) compared to its all-time maximum value?

Merck & Co dividend paid (ttm) is 100% of its all-time maximum value

What is Merck & Co dividend paid (ttm) compared to other companies from its sector (Healthcare)?

Merck & Co dividend paid (ttm) is higher than 99.15% of the companies in the same sector (Healthcare)

How has Merck & Co dividend paid (ttm) changed over the year?

Over the past year, Merck & Co dividend paid (ttm) has increased by 4.1%. During the same period, AstraZeneca has dropped by 0.4%, Novartis AG has risen by 5.1%, Thermo Fisher Scientific has grown by 13.1%, Danaher has grown by 45.6%

How has Merck & Co dividend paid (ttm) changed over the 3 years?

During the last 3 years, Merck & Co dividend paid (ttm) has increased by 17.4%. Over the same period, AstraZeneca has increased by 15.7%, Novartis AG has risen by 3.5%, Thermo Fisher Scientific has grown by 50.4%, Danaher has grown by 66.4%

How has Merck & Co dividend paid (ttm) changed over the 5 years?

For the past 5 years, Merck & Co dividend paid (ttm) has increased by 37.3%. In the same period, AstraZeneca has increased by 24.2%, Novartis AG has risen by 14.7%, Thermo Fisher Scientific has grown by 97.2%, Danaher has grown by 141.6%